CervoMed CRVO
NASDAQ CRVO
$2.31 +0.07 (+3.12%)
At close: Oct 23, 2026 · 4:00 PM EDT

CervoMed (CRVO) Gross Profit (2011 - 2013)

Updated

CervoMed (CRVO) reported Gross Profit of $71,667 for Q2 2013, down 49.7% from $142,484 a year earlier.

Analysis

CervoMed (CRVO) Gross Profit (2011 - 2013) Analysis & Trends

For FY2012, CervoMed posted Gross Profit of $138,739.

  • By year, Gross Profit came in at -$1.74 million in FY2011 and -$170,204 in FY2010.
  • The Q2 2013 figure ranks as the lowest quarterly Gross Profit since Q1 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 CervoMed 23.66 Mn -62.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 71,667.00
Sep 30, 2012 142,484.00
Jun 30, 2012 142,484.00
Mar 31, 2012 -68,960.00
Dec 31, 2011 -1.73 Mn
Sep 30, 2011 -3,609.00
API Access

CervoMed Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CRVO&period=max&api_key=YOUR_API_KEY